Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Geistlich Pharma AG | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
A prospective study examining bilateral 3rd molar extraction, by a split mouth protocol the investigators augment unilaterally and compare periodontal parameters in between.
40 patients will undergo bilateral 3rd molar extractions, in each patient one side would be augmented by a "Bio-Oss" xenograft.
Post operative, periodontal parameters such as pocket depth and mobility will be evaluated and compared.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 3rd molar | Experimental | Drug: Geistlich Bio Oss |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Geistlich Bio Oss | Drug | Extraction of Impacted 3rd Molars, |
|
| Measure | Description | Time Frame |
|---|---|---|
| Mobility (Scale 0,1,2,3), change is being assessed. | Mobility will be assessed in the intervals mentioned above, and compared over time. | Pre opp (base line), 1 month post opp, 3 months post opp, 6 months post opp |
| Pocket Depth (mm), change is being assessed. | Pocket depth will be assessed in the intervals mentioned above, and compared over time. | Pre opp (base line), 1 month post opp, 3 months post opp, 6 months post opp |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided